Evotec AG (OJ:EVT) Evotec To Present At The UBS Global Life Sciences Conference In New York

Evotec AG (OJ:EVT) Corporate news announcement processed and transmitted by Hugin ASA. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------


Hamburg, Germany - Evotec AG (Frankfurt Stock Exchange: EVT, NASDAQ: EVTC) today announced that Jörn Aldag, President & CEO and Dr John Kemp, Chief Research & Development Officer will present at the UBS Global Life Sciences Conference in New York.

Date: Wednesday, September 24, 2008 Time: 10.30 am EDT (04.30 pm CEST/03.30 pm BST) Venue: Grand Hyatt, New York City, US

A live webcast of the presentation will be accessible through the Evotec website at www.evotec.com - Investors. A replay will be available at www.evotec.com - Investors - Webcasts.

Contact: Anne Hennecke, Senior Vice President, Investor Relations & Corporate Communications, Evotec AG, Phone: +49-40-56081-286, anne.hennecke@evotec.com

--- End of Message ---

Evotec AG Schnackenburgallee 114 Hamburg Germany

WKN: 566480; ISIN: DE0005664809 ; Index: Prime All Share, CDAX, HDAX, MIDCAP, TECH All Share; Listed: Geregelter Markt in Frankfurter Wertpapierbörse, Prime Standard in Frankfurter Wertpapierbörse, Freiverkehr in Börse Berlin, Freiverkehr in Bayerische Börse München,

Freiverkehr in Börse Düsseldorf, Freiverkehr in Börse Stuttgart,

Freiverkehr in Hanseatische Wertpapierbörse zu Hamburg, Freiverkehr in Niedersächsische Börse zu Hannover;



LINK: http://hugin.info/131215/R/1252649/272554.pdf

Evotec AG

http://www.evotec.com

ISIN: DE0005664809

Stock Identifier: XFRA.EVT